AUSTIN, Texas and OXFORD, U.K., Dec. 7, 2021 (SEND2PRESS NEWSWIRE) — Pure Transplant Solutions, LLC (PTS), a developer of novel HLA based transplant diagnostics, and Oxford Immunotec, Ltd. (OI), a global diagnostics company part of PerkinElmer Inc., today announce an exclusive sublicense agreement in which PTS will obtain exclusive commercial rights to issued patents protecting […]
Archive | Biotechnology
Press Release: Neurotech Reports Announces Launch of New Publication Serving Bioelectronic Medicine Industry
By Send2Press Newswire on November 8, 2021 in Biotechnology, Books and Publishing, Business, Press Releases, Product Launches, SAN FRANCISCO, Calif.
SAN FRANCISCO, Calif., Nov. 8, 2021 (SEND2PRESS NEWSWIRE) — Neurotech Reports, the San Francisco, California publisher of market intelligence for the healthcare industry, announced the launch of a new monthly newsletter covering the bioelectronic medicine industry, one of the newest and fastest growing industry segments. The publication, BioElectRx Business Report, is the first industry newsletter […]
Press Release: Kalyagen™ Announces Registration of STEMREGEN® in Spain, CEO at Madrid Stem Cell Symposium
By Send2Press Newswire on October 12, 2021 in AUSTIN, Texas, Biotechnology, Business, Press Releases
AUSTIN, Texas, Oct. 12, 2021 (SEND2PRESS NEWSWIRE) — Kalyagen is pleased to announce the successful product registration of STEMREGEN® in Spain. This announcement coincides with Christian Drapeau’s, CEO and Chief Scientist of Kalyagen, trip to Madrid, Spain last week to speak at the IV Jornadas Internacionales Otto H. Warburg symposium at the NH Madrid Príncipe […]
Press Release: iCell Gene Therapeutics Announces cCAR-T Clinical Publication in the Stem Cell Reviews and Reports Journal
By Send2Press Newswire on September 10, 2021 in Biotechnology, Business, Drugs and Pharmaceuticals, Press Releases, Reports and Studies
STONY BROOK, N.Y., Sept. 10, 2021 (SEND2PRESS NEWSWIRE) — iCell Gene Therapeutics, a clinical stage biopharmaceutical company focused on immunotherapies for hematologic malignancies, solid tumors, organ rejections and autoimmune disorders, today announced the publication of their clinical study utilizing cCAR T-cell immunotherapy to successfully treat a patient with lupus.
Press Release: Vyriad, Inc. Appoints Harry Hoffman to its Board of Directors
ROCHESTER, Minn., Aug. 24, 2021 (SEND2PRESS NEWSWIRE) — Vyriad, Inc., a clinical-stage biotechnology company developing oncolytic virus therapies to treat a wide range of cancers, today announced the appointment of leading life sciences investor Harry Hoffman to the Company’s board of directors.
Press Release: KROST Acts as Exclusive Financial Advisor for Integrity Bio in Sale to Curia
By Send2Press Newswire on August 11, 2021 in Biotechnology, Business, Consulting, Finance, LOS ANGELES, Calif., Mergers and Acquisitions, Press Releases, Taxes and Accounting
LOS ANGELES, Calif., Aug. 11, 2021 (SEND2PRESS NEWSWIRE) — Integrity Bio, Inc., a privately held formulation and fill-finish organization, was sold to Curia (formerly Albany Molecular Research, Inc. (AMRI)), a Contract Development and Manufacturing Organization (CDMO) and leading global provider of advanced contract research, development, and manufacturing solutions. KROST, a Los Angeles-based firm, acted as […]
Press Release: Pure Transplant Solutions, LLC Announces Research Collaboration with the Department of Surgery at the University of Cambridge
By Send2Press Newswire on July 21, 2021 in Alliances and Partnerships, AUSTIN, Texas, Biotechnology, Business, Press Releases
AUSTIN, Texas and CAMBRIDGE, U.K., July 21, 2021 (SEND2PRESS NEWSWIRE) — Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a research collaboration with The University of Cambridge […]
Press Release: BioAustin Appoints New Leadership and Unveils An Expanded Strategic Focus In Central Texas As BioAustinCTX
By Send2Press Newswire on June 3, 2021 in AUSTIN, Texas, Biotechnology, Business, NonProfit and Charities, Press Releases
AUSTIN, Texas, June 3, 2021 (SEND2PRESS NEWSWIRE) — Life Science industry organization BioAustin today announced changes to its leadership team, brand positioning, and long-term strategy focused on facilitating the continued growth of the life science industry in Central Texas. Over the past several years, Austin and the Central Texas region have developed into one of […]
Press Release: Pure MHC, LLC Announces Launch of Contract Research Service Division and Initial Collaboration Project with argenx
By Send2Press Newswire on March 31, 2021 in AUSTIN, Texas, Biotechnology, Business, Press Releases, Product Launches
AUSTIN, Texas, March 31, 2021 (SEND2PRESS NEWSWIRE) — Pure MHC, LLC, a target discovery and development company, today announced the launch of its contract research services arm, Pure MHC Solutions, and an initial collaboration project with global immunology company, argenx.
Press Release: Pure Transplant Solutions Announces Collaboration with Innobiochips to Develop Personalized Diagnostics for Post-Transplant Monitoring and Early Detection of Transplant Rejection
By Send2Press Newswire on March 24, 2021 in Alliances and Partnerships, AUSTIN, Texas, Biotechnology, Business, Press Releases, Surgery and Neurotechnology
AUSTIN, Texas and LOOS, France, March 24, 2021 (SEND2PRESS NEWSWIRE) — Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a collaboration agreement with Innobiochips (IBC).